Astrid A. Glück

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index128citations13works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(8), Cancer-related Molecular Pathways(4), Liver physiology and pathology(4), Microtubule and mitosis dynamics(2), PI3K/AKT/mTOR signaling in cancer(2)

Publications13 total

Data from Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation
2023Open Access
Data from Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation
2023Open Access
Abstract A52: Deciphering MET-dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics reveals Ser1016 as a novel MET phosphosite that regulates cellular response to irradiation
Cancer Research·2020
Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
Molecular Oncology·2020· 9 citedOpen Access
Abstract 4423: Antitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123
Molecular and Cellular Biology / Genetics·2019
Abstract 4423: Antitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123
Cancer Research·2019· 5 cited
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia
Oncogene·2018· 21 cited
Abstract A20: The DNA damage-induced phosphoproteome is modulated by inhibition of the MET receptor
Clinical Cancer Research·2017
Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation
Molecular Cancer Research·2015· 32 cited
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer
Genes & Cancer·2015· 6 citedOpen Access
Interplay between receptor tyrosine kinases and hypoxia signaling in cancer
The International Journal of Biochemistry & Cell Biology·2015· 28 cited
518: miR-125b confers NF-κB activity and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas
European Journal of Cancer·2014
Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation
FEBS Letters·2014· 27 citedOpen Access

Frequent Co-authors

Michaela Medová(10), Daniel M. Aebersold(10), Yitzhak Zimmer(10), Paola Francica(7), Andree Blaukat(6), Lluís Nisa(4), Mario P. Tschan(4), Kei Mikami(3), Friedhelm Bladt(3), Eleonora Orlando(3), Ariel Bensimon(3), Jonas P. Koch(3), Ruedi Aebersold(3), Dominic Leiser(2), Aurélie Quintin(2), Jacopo Gavini(2), Deborah Stroka(2), Selina M. Roth(2), Rahel Riedo(2), Gérald Gavory(2)